Litcius/Paper detail

Transcription factor c-Jun modulates GLUT1 in glycolysis and breast cancer metastasis

Ping Zhu, Guoping Liu, Xue Wang, Jingjing Lu, Yue Zhou, Shuyi Chen, Yabiao Gao, Chaofu Wang, Jerry Yu, Yangbai Sun, Ping Zhou

2022BMC Cancer34 citationsDOIOpen Access PDF

Abstract

As the main isoforms of membranous glucose transporters (GLUT), GLUT1 involves tumorigenesis, metastasis and prognosis in a variety of cancers. However, its role in breast cancer metastasis remains to be elucidated. Here we examined its transcriptional and survival data in patients with breast cancer from several independent databases including the Oncomine, Gene Expression Profiling Interactive Analysis, Gene Expression across Normal and Tumor tissue, UALCAN, cBioPortal, Kaplan-Meier Plotter and PROGgeneV2. We found that its mRNA expression was significantly high in cancer tissues, which was associated with metastasis and poor survival. Transcription factor c-Jun might bind to GLUT1 promoter to downregulate its gene expression or mRNA stability, therefore to suppress glycolysis and metastasis. By qRT-PCR, we verified that GLUT1 was significantly increased in 38 paired human breast cancer samples while JUN was decreased. Furthermore, the protein level of GLUT1 was higher in tumor than in normal tissues by IHC assay. To explore underlying pathways, we further performed GO and KEGG analysis of genes related to GLUT1 and JUN and found that GLUT1 was increased by transcription factor c-Jun in breast cancer tissues to influence glycolysis and breast cancer metastasis.

Topics & Concepts

GLUT1Breast cancerSurgical oncologyMetastasisCancer researchCarcinogenesisTranscription factorHIF1ABiologyMedicineCancerGlucose transporterOncologyInternal medicineGeneAngiogenesisGeneticsInsulinMetabolism, Diabetes, and CancerCancer, Hypoxia, and MetabolismRNA modifications and cancer